MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Clinical trials for MULTI-DRUG RESISTANT NEPHROTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MULTI-DRUG RESISTANT NEPHROTIC SYNDROME trials appear
Sign up with your email to follow new studies for MULTI-DRUG RESISTANT NEPHROTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on lupus and kidney disease
Disease control Recruiting nowThis early-stage study is testing a new treatment for autoimmune diseases like lupus, kidney disease, and scleroderma. It uses specially engineered immune cells (CAR T-cells) from a healthy donor to target and calm the overactive immune system. The main goal is to check safety an…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 17, 2026 01:16 UTC
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowThis early-phase study tests a new treatment using specially engineered natural killer (NK) cells to target and calm overactive B cells in children with autoimmune diseases like lupus and IgA nephropathy. The goal is to see if this therapy is safe and can help control the disease…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Engineered immune cells aim to tame autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new treatment called QT-219C, which uses specially engineered immune cells (CAR-T cells) to target and destroy faulty B cells that cause autoimmune diseases like lupus and kidney disease. The treatment involves a one-time infusion after a short chem…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 08, 2026 12:02 UTC